Theriva BiologicsTOVX
13F holders, Q2 2026 (June 30)26holders +4
6new positions
2sold out
1famous investor
$0.25avg. 13F price*
At the end of Q2 2026, 26 institutions reported holding Theriva Biologics Inc. (TOVX) in their 13F filings, up 4 from Q1 2026. 6 opened new positions and 2 sold out. The largest holders were Vanguard Capital Management LLC ($122K), Jane Street Group, LLC ($83K) and Geode Capital Management, LLC ($74K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Theriva Biologics Inc.
- CUSIP
- 87164U508
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $52K |
| Exits | 2 | $5K |
All 13F filers, Q1 2026 → Q2 2026: 655,207 shares bought and 640,112 shares sold, net +15,095 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Vanguard Capital Management LLC | 0.00% | Add +152.7% | 486,179 | $122K |
| Jane Street Group, LLC | 0.00% | Add +87.5% | 331,922 | $83K |
| Geode Capital Management, LLC | 0.00% | Reduce -34.7% | 294,021 | $74K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 241,780 | $60K |
| Ikarian Capital, LLC | 0.00% | No change | 112,076 | $28K |
| Virtu Financial LLC | 0.00% | Reduce -65.6% | 87,138 | $22K |
| Northern Trust Corp. | 0.00% | New | 82,700 | $21K |
| Renaissance Technologies | 0.00% | New | 63,710 | $16K |
| UBS Group AG | 0.00% | Reduce -72.9% | 61,053 | $15K |
| XTX Topco Ltd | 0.00% | Reduce -43.1% | 53,868 | $13K |
| Ground Swell Capital, LLC | 0.01% | New | 35,292 | $9K |
| Boothbay Fund Management, LLC | 0.00% | No change | 27,646 | $7K |
| Susquehanna International Group, LLP | 0.00% | New | 24,064 | $6K |
| Morgan Stanley | 0.00% | Reduce -14.0% | 20,299 | $5K |
| Two Sigma Securities, LLC | 0.00% | Reduce -81.2% | 19,748 | $5K |
| Two Sigma Investments, LP | 0.00% | Add +0.1% | 15,456 | $4K |
| Schwarz Dygos Wheeler Investment Advisors LLC | 0.00% | No change | 15,000 | $4K |
| BlackRock, Inc. | 0.00% | No change | 7,504 | $2K |
| Osaic Holdings, Inc. | 0.00% | Add +5412.5% | 441 | $110 |
| SBI Securities Co., Ltd. | 0.00% | Add +173.3% | 358 | $90 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 100 | $25 |
| IFP Advisors, Inc | 0.00% | No change | 11 | $3 |
| Barclays PLC | 0.00% | New | 3 | $1 |
| NFSG Corp | 0.00% | No change | 5 | $1 |
| Danske Bank A/S | 0.00% | No change | 1 | $0 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is TOVX's weight in each manager's 13F, not the share of Theriva Biologics Inc. the manager owns.